Cresco Labs Operating Margin 2020-2025 | CRLBF
Current and historical operating margin for Cresco Labs (CRLBF) over the last 10 years. The current operating profit margin for Cresco Labs as of June 30, 2025 is -6.40%.
| Cresco Labs Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2025-06-30 | $0.69B | $0.08B | 10.93% |
| 2025-03-31 | $0.71B | $0.09B | 12.89% |
| 2024-12-31 | $0.72B | $0.11B | 14.64% |
| 2024-09-30 | $0.74B | $0.11B | 15.49% |
| 2024-06-30 | $0.75B | $-0.02B | -2.68% |
| 2024-03-31 | $0.76B | $-0.06B | -8.28% |
| 2023-12-31 | $0.77B | $-0.09B | -11.41% |
| 2023-09-30 | $0.78B | $-0.26B | -32.95% |
| 2023-06-30 | $0.80B | $-0.13B | -16.71% |
| 2023-03-31 | $0.82B | $-0.10B | -12.17% |
| 2022-12-31 | $0.84B | $-0.08B | -9.98% |
| 2022-09-30 | $0.86B | $0.08B | 8.72% |
| 2022-06-30 | $0.87B | $-0.21B | -23.70% |
| 2022-03-31 | $0.86B | $-0.21B | -24.85% |
| 2021-12-31 | $0.82B | $-0.22B | -26.43% |
| 2021-09-30 | $0.77B | $-0.23B | -30.46% |
| 2021-06-30 | $0.70B | $0.06B | 7.97% |
| 2021-03-31 | $0.59B | $0.02B | 3.41% |
| 2020-12-31 | $0.48B | $-0.02B | -5.05% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.683B | $0.724B |
| Cresco Labs Inc. is an integrated multistate cannabis operators principally in the United States. Its brands are designed to meet the needs of all consumer segments and comprised of brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Cresco Labs Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.027B | 26.85 |
| Boston Scientific (BSX) | United States | $157.644B | 37.59 |
| Stryker (SYK) | United States | $150.755B | 30.69 |
| EssilorLuxottica (ESLOY) | France | $144.001B | 0.00 |
| Medtronic (MDT) | Ireland | $118.256B | 16.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.628B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.188B | 24.69 |
| ResMed (RMD) | United States | $41.753B | 29.86 |
| GE HealthCare Technologies (GEHC) | United States | $33.827B | 15.90 |
| Agilent Technologies (A) | United States | $33.605B | 21.91 |
| Koninklijke Philips (PHG) | Netherlands | $26.779B | 17.71 |
| Terumo (TRUMY) | Japan | $26.532B | 31.44 |
| Insulet (PODD) | United States | $23.358B | 78.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.303B | 13.56 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.337B | 0.00 |
| Baxter (BAX) | United States | $12.584B | 9.72 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.027B | 29.48 |
| Lantheus Holdings (LNTH) | United States | $3.785B | 10.23 |
| Envista Holdings (NVST) | United States | $3.513B | 24.58 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.268B | 14.50 |
| Perrigo (PRGO) | Ireland | $3.265B | 8.15 |
| ICU Medical (ICUI) | United States | $3.109B | 21.17 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.157B | 46.25 |
| Acuren (TIC) | United States | $2.156B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.117B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.896B | 11.93 |
| Green Thumb Industries (GTBIF) | United States | $1.888B | 81.09 |
| AtriCure (ATRC) | United States | $1.882B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.596B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.323B | 16.91 |
| AdaptHealth (AHCO) | United States | $1.246B | 17.71 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.223B | 19.41 |
| Kestra Medical Technologies (KMTS) | United States | $0.952B | 0.00 |
| InMode (INMD) | Israel | $0.941B | 8.70 |
| Valneva SE (VALN) | France | $0.762B | 0.00 |
| SNDL (SNDL) | Canada | $0.649B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.618B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.615B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.62 |
| Surmodics (SRDX) | United States | $0.496B | 0.00 |
| Evolus (EOLS) | United States | $0.495B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 16.11 |
| CeriBell (CBLL) | United States | $0.420B | 0.00 |
| Owens & Minor (OMI) | United States | $0.387B | 3.43 |
| Sanuwave Health (SNWV) | United States | $0.360B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.353B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.352B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.301B | 61.15 |
| Sanara MedTech (SMTI) | United States | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.299B | 0.00 |
| Omeros (OMER) | United States | $0.298B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.296B | 0.00 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 20.74 |
| Cerus (CERS) | United States | $0.255B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.255B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.241B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Quanterix (QTRX) | United States | $0.218B | 0.00 |
| Exagen (XGN) | United States | $0.218B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.195B | 16.24 |
| FitLife Brands (FTLF) | United States | $0.173B | 21.31 |
| Biote (BTMD) | United States | $0.164B | 5.43 |
| Jushi Holdings (JUSHF) | United States | $0.151B | 0.00 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| MacroGenics (MGNX) | United States | $0.114B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.114B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.32 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.058B | 0.00 |
| ImmuCell (ICCC) | United States | $0.057B | 32.90 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 33.67 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 14.62 |
| Trinity Biotech (TRIB) | Ireland | $0.027B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.016B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |